UBS analyst Michael Lasser reiterated a Buy rating and $147.00 price target on Walmart (NASDAQ: WMT).

The analyst commented, "Overall, we think WMT’s upcoming print should deliver on the key elements that the market is expecting. Interestingly, we believe there's a high degree of conformity around what is anticipated. This includes a ~4.5% WMT US comp driven by 25%+ e-commerce growth, offset by a moderate decline in store sales resulting from softer trends in health and wellness. We think it’s pretty well understood that the drag from the Maximum Fair Pricing legislation and the slow adoption of the oral GLP-1 medicines will likely result in a slowdown for the pharmacy business. Still, it’s expected that the Walmart US segment will generate operating income at least at the high end of the company’s overall 6-8% growth rate."

For an analyst ratings summary and ratings history on Walmart click here. For more ratings news on Walmart click here.

Shares of Walmart closed at $131.47 yesterday.